VYNE Therapeutics
VYNE
#10264
Rank
โ‚ฌ11.49 M
Marketcap
0,35ย โ‚ฌ
Share price
7.22%
Change (1 day)
-86.22%
Change (1 year)

VYNE Therapeutics (VYNE) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ30.88 Million

According to VYNE Therapeutics's latest financial reports the company's total assets are โ‚ฌ30.88 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

VYNE Therapeutics - Total assets on balance sheet (from 2016 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ64.29 M-27.24%
2023-12-31โ‚ฌ88.36 M132.56%
2022-12-31โ‚ฌ37.99 M-35.82%
2021-12-31โ‚ฌ59.2 M-22.32%
2020-12-31โ‚ฌ76.21 M7.84%
2019-12-31โ‚ฌ70.67 M-42.22%
2018-12-31โ‚ฌ0.12 B119.48%
2017-12-31โ‚ฌ55.72 M39.39%
2016-12-31โ‚ฌ39.97 M-0.39%
2015-12-31โ‚ฌ40.13 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
ORIC Pharmaceuticals
ORIC
โ‚ฌ0.36 B 1,093.38%๐Ÿ‡บ๐Ÿ‡ธ USA